Skip to content
value.today

SciFluor Life Sciences, Inc.

Formerly SciFluor Life Sciences, Inc.

Total raised
$57 M
2 rounds on record
Latest round
$26 M
Dec 2023
First round on record
Apr 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of SciFluor Life Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$26 MNo. 2$10 to $50 million

SciFluor Life Sciences, Inc.: Raise no. 2, Dec 2023

Investors in this round

279 investors had bought by the notice of Feb 22, 2024: 279 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $26 M offered
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$2,562,544
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • D. Scott Edwards · Executive Officer
  • David J. Tanzer · Executive Officer
  • Kerrie Brady · Executive Officer, Director
  • William Scott Steinkrauss · Executive Officer
  • Barbara H. Ryan · Director
  • Brenton Scott Saunders · Director
  • Bruce H. Failing · Director
  • Robert H. Ruffolo · Director
  • Robin H. Steele · Director
  • William H. Koster · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On the use of proceeds: “A portion of the proceeds of this transaction may be used to pay the salaries of the Issuer's executive employees listed on Item 3 in the ordinary course of business.”

Signed by Kerrie Brady, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 22, 2024. Read the notice at the SEC.

equity, debt, optionsSEC
Apr 2021$32 MNo. 1$10 to $50 million

SciFluor Life Sciences, Inc.: Raise no. 1, Apr 2021

Investors in this round

226 investors had bought by the notice of Aug 24, 2021: 226 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$32 M of $50 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$4,867,500
Finders' fees
none
Paid to its own people
$5,525,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Scott Edwards · Executive Officer, Promoter
  • Kerrie H. Brady · Executive Officer, Director
  • Brent H. Saunders · Director
  • Robert H. Dempsey · Director
  • Robert H. Ruffolo · Director
  • Robin H. Steele · Director
  • William H. Koster · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Maxim to receive 10% (5% for certain investors introduced by issuer) cash fee of total offering amount less $1,325,000 in converted notes, and 10% common stock warrant coverage.”

Signed by D. Scott Edwards, Chief Development Operations Officer. Source: SEC Form D and 1 amendment, newest notice filed Aug 24, 2021. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • SciFluor Life Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2024).

    SEC Form D · Feb 2024

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Feb 2024

That is all the official record says: SciFluor Life Sciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of SciFluor Life Sciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 279 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by SciFluor Life Sciences, Inc.
NameRoleNamed in
D. Scott EdwardsExecutive officerFeb 2024
David J. TanzerExecutive officerFeb 2024
Kerrie BradyExecutive officerFeb 2024
William Scott SteinkraussExecutive officerFeb 2024
David Scott EdwardsExecutive officerAug 2021
Kerrie H. BradyExecutive officerAug 2021
Barbara H. RyanDirectorFeb 2024
Brenton Scott SaundersDirectorFeb 2024
Bruce H. FailingDirectorFeb 2024
Kerrie BradyDirectorFeb 2024
Robert H. RuffoloDirectorFeb 2024
Robin H. SteeleDirectorFeb 2024
William H. KosterDirectorFeb 2024
Brent H. SaundersDirectorAug 2021
Kerrie H. BradyDirectorAug 2021
Robert H. DempseyDirectorAug 2021
David Scott EdwardsPromoterAug 2021